2024 Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison IACOBELLI, SIMONA
2024 Plain language summary of RACE study results: addition of eltrombopag to standard treatment of severe aplastic anemia IACOBELLI, SIMONA
2023 Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modelling IACOBELLI, SIMONA
2023 Pollen variability in Quercus L. species and relative systematic implications DI MARCO, GABRIELE; D'AGOSTINO, ALESSIA; BRAGLIA, ROBERTO; REDI, ENRICO LUIGI; IACOBELLI, SIMONA; GISMONDI, ANGELO; CANINI, ANTONELLA
2023 An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT IACOBELLI, SIMONA
2022 Impact of donor-derived CD34+infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT IACOBELLI, SIMONA
2022 Analyzing differences between restricted mean survival time curves using pseudo-values IACOBELLI, SIMONA
2022 Outcomes and toxicity of allogeneic HCT in CML patients previously treated with second generation TKIs: a prospective non-interventional study from the Chronic Malignancy Working Party of EBMT IACOBELLI, SIMONA
2022 Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP SBIANCHI, GIULIA; IACOBELLI, SIMONA
2022 Complement C3 inhibition in severe COVID-19 using compstatin AMY-101 IACOBELLI, SIMONA
2022 Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia IACOBELLI, SIMONA
2022 Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study SBIANCHI, GIULIA; IACOBELLI, SIMONA
2021 Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT IACOBELLI, SIMONA
2021 Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation IACOBELLI, SIMONA
2021 Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14): a study from the CMWP-EBMT IACOBELLI, SIMONA
2021 IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study SBIANCHI, GIULIA; IACOBELLI, SIMONA
2021 Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT SBIANCHI, GIULIA; IACOBELLI, SIMONA; TANASE, ANDREI VALENTIN
2020 Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP IACOBELLI, SIMONA
2020 Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT) IACOBELLI, SIMONA
2020 Allogeneic transplantation in multiple myeloma - Does it still have a place? IACOBELLI, SIMONA
2020 Intercontinental study on pre-engraftment and post-engraftment Gram-negative rods bacteremia in hematopoietic stem cell transplantation patients: risk factors and association with mortality IACOBELLI, SIMONA
2020 Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation IACOBELLI, SIMONA
2020 Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy RUGGERI, ANNALISA; IACOBELLI, SIMONA
2020 Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixafor IACOBELLI, SIMONA
2020 Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT IACOBELLI, SIMONA
2020 Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors IACOBELLI, SIMONA
2020 Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation IACOBELLI, SIMONA
2019 Association of aplastic anaemia and lymphoma: a report from the severe aplastic anaemia working party of the European Society of Blood and Bone Marrow Transplantation. IACOBELLI, SIMONA
2019 EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL) IACOBELLI, SIMONA
2019 Impact of T-cell depletion strategies on outcomes following hematopoietic stem cell transplantation for idiopathic aplastic anemia: a study on behalf of the European blood and marrow transplant severe aplastic anemia working party. IACOBELLI, SIMONA; SBIANCHI, GIULIA
2018 Incidence of Second Primary Malignancies after Autologous Transplantion for Multiple Myeloma in the Era of Novel Agents. IACOBELLI, SIMONA
2018 Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita IACOBELLI, SIMONA
2018 Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion IACOBELLI, SIMONA
2018 Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma. IACOBELLI, SIMONA
2018 Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: A study from the chronic malignancies working party of the EBMT IACOBELLI, SIMONA; ARCESE, WILLIAM
2018 Protective Environment for Hematopoietic Cell Transplant (HSCT) Recipients: The Infectious Diseases Working Party EBMT Analysis of Global Recommendations on Health-Care Facilities IACOBELLI, SIMONA
2018 Melphalan 140mg/M2 Or 200mg/M2 For Autologous Transplantation In Myeloma: Results From The Collaboration To Collect Autologous Transplant Outcomes In Lymphoma And Myeloma (CALM) Study. A Report By The EBMT Chronic Malignancies Working Party IACOBELLI, SIMONA
2017 Salvage use of allogeneic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the EBMT Chronic Malignancies Working Party IACOBELLI, SIMONA
2017 High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation IACOBELLI, SIMONA
2017 Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial) IACOBELLI, SIMONA
2017 Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT) IACOBELLI, SIMONA
2017 Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group IACOBELLI, SIMONA
2016 Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation IACOBELLI, SIMONA
2016 Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research IACOBELLI, SIMONA
2016 Survival probabilities with time-dependent treatment indicator: quantities and non-parametric estimators IACOBELLI, SIMONA
2016 Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties IACOBELLI, SIMONA
2016 Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study IACOBELLI, SIMONA; ARCESE, WILLIAM
2016 Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party IACOBELLI, SIMONA
2016 Partially anaortic clampless off-pump coronary artery bypass prevents neurologic injury compared to on-pump coronary surgery: a propensity score-matched study on 286 patients BASSANO, CARLO; UVA, FLORIANO; IACOBELLI, SIMONA; RUVOLO, GIOVANNI
2015 Impact of complete remission before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial IACOBELLI, SIMONA
2015 Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation IACOBELLI, SIMONA
2015 Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease? IACOBELLI, SIMONA
2015 Efficacy and outcome of allogeneic transplantation in IgD and nonsecretory myeloma. A report on behalf of the Myeloma Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation IACOBELLI, SIMONA
2015 Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma IACOBELLI, SIMONA
2015 Current practices used for the prevention of central venous catheter-associated infection in hematopoietic stem cell transplantation recipients: a survey from the Infectious Diseases Working Party and Nurses' Group of EBMT IACOBELLI, SIMONA
2014 Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT. IACOBELLI, SIMONA
2014 Allogenic hematopoietic stem cell transplantation in patients with polycythemia or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: report from the MPN subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation IACOBELLI, SIMONA
2014 Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemia IACOBELLI, SIMONA
2013 Lymphoproliferative Disorders After Hematopoietic Stem Cell Transplantation in Children and Adults: a Study From the Infectious Diseases Working Group of the European Group for Blood and Marrow Transplantation IACOBELLI, SIMONA
2013 Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation MIGLIAVACCA, MADDALENA; IACOBELLI, SIMONA
2013 Retinoic acid and arsenic trioxide for acute promyelocytic leukemia LO COCO, FRANCESCO; IACOBELLI, SIMONA; VENDITTI, ADRIANO; AMADORI, SERGIO
2013 Length of stay in different drug using states: lifestyles of problem and recreational drug consumers IACOBELLI, SIMONA; ROSSI, CARLA
2013 Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation IACOBELLI, SIMONA
2013 Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation IACOBELLI, SIMONA
2013 Multiple time scales in multi-state models IACOBELLI, SIMONA
2013 Autologous/reduced-intensity allogeneic stem cell transplantation versus autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study IACOBELLI, SIMONA
2012 The Cox shared frailty model with log-skew-normal frailties IACOBELLI, SIMONA
2012 Superiority of the Triple Combination of Bortezomib-Thalidomide-Dexamethasone Over the Dual Combination of Thalidomide-Dexamethasone in Patients With Multiple Myeloma Progressing or Relapsing After Autologous Transplantation: The MMVAR/IFM 2005-04 Randomized Phase III Trial From the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation IACOBELLI, SIMONA
2012 Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study BIANCONE, LIVIA; ZUZZI, SARA; CALABRESE, EMMA; IACOBELLI, SIMONA; PALLONE, FRANCESCO
2011 Tandem autologous/reduced-intensity allogeneic stem cell transplantation versus autologous transplantation in myeloma: long-term follow-up IACOBELLI, SIMONA
2010 Outcome of patients developing GvHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT IACOBELLI, SIMONA
2010 Evaluation of short- and long-term response to treatment in GIMEMA protocol for Acute Myeloid Leukaemia IACOBELLI, SIMONA
2010 Efficacy and outcome of autologous transplantation in rare myelomas IACOBELLI, SIMONA
2010 Primary plasma cell leukemia and autologous stem cell transplantation IACOBELLI, SIMONA
2008 Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia IACOBELLI, SIMONA; AMADORI, SERGIO
2008 Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia LO COCO, FRANCESCO; IACOBELLI, SIMONA; AMADORI, SERGIO
2008 M4 acute myeloid leukemia: the role of eosinophilia and cytogenetics in treatment response and survival. The GIMEMA experience. IACOBELLI, SIMONA; BERNARDI, MAURO; VENDITTI, ADRIANO
2008 Assessment of the role of timing of second transplantation in multiple myeloma by multistate modeling IACOBELLI, SIMONA
2007 Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma IACOBELLI, SIMONA
2007 Pharmacogenetic analysis of liver toxicity after busulfan/cyclophosphamide-based allogeneic hematopoietic stem cell transplantation IACOBELLI, SIMONA
2007 Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning IACOBELLI, SIMONA
2006 Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes IACOBELLI, SIMONA
2006 The effect of prior exposure to imatinib on transplant-related mortality IACOBELLI, SIMONA
2006 ZAP-70 expression in acute lymphoblastic leukemia: association with the E2A/PBX1 rearrangement and the pre-B stage of differentiation and prognostic implications IACOBELLI, SIMONA
2006 Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis: a report from the European Group for Blood and Marrow Transplantation IACOBELLI, SIMONA
2005 The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants IACOBELLI, SIMONA
2005 Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma IACOBELLI, SIMONA
2005 Role of stem cell transplantation in myeloma IACOBELLI, SIMONA
2004 Benefit and timing of second transplantations in multiple myeloma: clinical findings and methodological limitations in a European Group for Blood and Marrow Transplantation registry study IACOBELLI, SIMONA
2003 Stem cell transplantation for chronic myeloid leukemia in children IACOBELLI, SIMONA; ARCESE, WILLIAM
2002 Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia IACOBELLI, SIMONA